Moors & Cabot, Inc. Illumina, Inc. Transaction History

Moors & Cabot, Inc.

$1.96 Billion
Q3 2024

A detailed history of Moors & Cabot, Inc. transactions in Illumina, Inc. stock. As of the latest transaction made, Moors & Cabot, Inc. holds 5,818 shares of ILMN stock, worth $787,000. This represents 0.04% of its overall portfolio holdings.

Number of Shares

5,818

Previous 5,723 1.66%

Holding current value

$787,000

Previous $597,000 26.97%

% of portfolio

0.04%

Previous 0.03%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$105.28 - $135.9 $10,001 - $12,910	95 Added 1.66%	5,818 $758,000
Q2 2024 Aug 09, 2024	SELL	$101.05 - $133.57 $52,849 - $69,857	-523 Reduced 8.37%	5,723 $597,000
Q1 2024 May 08, 2024	BUY	$127.73 - $147.2 $16,093 - $18,547	126 Added 2.06%	6,246 $857,000
Q4 2023 Feb 14, 2024	SELL	$92.79 - $142.53 $16,238 - $24,942	-175 Reduced 2.78%	6,120 $852,000
Q3 2023 Nov 07, 2023	SELL	$128.91 - $192.44 $10,312 - $15,395	-80 Reduced 1.25%	6,295 $864,000
Q2 2023 Aug 09, 2023	SELL	$183.43 - $232.67 $88,963 - $112,844	-485 Reduced 7.07%	6,375 $1.2 Million
Q1 2023 May 04, 2023	BUY	$193.75 - $232.55 $13,562 - $16,278	70 Added 1.03%	6,860 $1.6 Million
Q4 2022 Feb 09, 2023	BUY	$187.24 - $242.74 $13,106 - $16,991	70 Added 1.04%	6,790 $1.37 Million
Q4 2022 Feb 06, 2023	SELL	$187.24 - $242.74 $16,851 - $21,846	-90 Reduced 1.32%	6,720 $1.36 Million
Q3 2022 Nov 07, 2022	BUY	$177.23 - $227.44 $20,381 - $26,155	115 Added 1.72%	6,810 $1.3 Million
Q2 2022 Aug 08, 2022	SELL	$181.58 - $368.0 $1,815 - $3,680	-10 Reduced 0.15%	6,695 $1.23 Million
Q1 2022 May 13, 2022	SELL	$303.87 - $423.8 $4,558 - $6,357	-15 Reduced 0.22%	6,705 $2.34 Million
Q4 2021 Feb 14, 2022	BUY	$347.28 - $421.83 $25,698 - $31,215	74 Added 1.11%	6,720 $2.56 Million
Q3 2021 Dec 08, 2021	BUY	$405.61 - $524.84 $2.7 Million - $3.49 Million	6,646 New	6,646 $2.7 Million
Q3 2021 Nov 05, 2021	SELL	$405.61 - $524.84 $2.56 Million - $3.31 Million	-6,304 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$372.84 - $481.5 $32,437 - $41,890	87 Added 1.4%	6,304 $2.98 Million
Q1 2021 May 12, 2021	SELL	$361.28 - $504.76 $36,128 - $50,476	-100 Reduced 1.58%	6,217 $2.39 Million
Q3 2020 Nov 09, 2020	BUY	$268.51 - $400.74 $138,282 - $206,381	515 Added 8.88%	6,317 $1.95 Million
Q2 2020 Aug 13, 2020	SELL	$256.46 - $373.01 $102,071 - $148,457	-398 Reduced 6.42%	5,802 $2.15 Million
Q1 2020 May 12, 2020	SELL	$209.2 - $335.53 $42,886 - $68,783	-205 Reduced 3.2%	6,200 $1.69 Million
Q4 2019 Jan 28, 2020	SELL	$288.29 - $335.49 $28,829 - $33,549	-100 Reduced 1.54%	6,405 $2.13 Million
Q3 2019 Oct 22, 2019	SELL	$266.84 - $378.23 $40,025 - $56,734	-150 Reduced 2.25%	6,505 $1.98 Million
Q1 2019 May 06, 2019	SELL	$272.57 - $321.18 $1.81 Million - $2.14 Million	-6,655 Reduced 50.0%	6,655 $2.07 Million
Q1 2019 May 01, 2019	BUY	$272.57 - $321.18 $1.69 Million - $1.99 Million	6,205 Added 87.33%	13,310 $4.13 Million
Q4 2018 Feb 13, 2019	SELL	$272.46 - $366.54 $54,491 - $73,308	-200 Reduced 2.74%	7,105 $2.13 Million
Q3 2018 Nov 14, 2018	BUY	$279.04 - $367.06 $133,939 - $176,188	480 Added 7.03%	7,305 $2.68 Million
Q2 2018 Aug 14, 2018	SELL	$228.17 - $292.07 $28,521 - $36,508	-125 Reduced 1.8%	6,825 $1.91 Million
Q1 2018 May 18, 2018	SELL	$209.54 - $253.91 $194,034 - $235,120	-926 Reduced 11.76%	6,950 $1.64 Million
Q4 2017 Feb 13, 2018	BUY	$202.23 - $230.03 $76,038 - $86,491	376 Added 5.01%	7,876 $1.72 Million
Q3 2017 Nov 16, 2017	BUY	$172.3 - $213.93 $86,150 - $106,965	500 Added 7.14%	7,500 $1.5 Million
Q2 2017 Aug 15, 2017	BUY	N/A	7,000	7,000 $1.21 Million

Others Institutions Holding ILMN

# of Institutions

900

Shares Held

137M

Call Options Held

1.22M

Put Options Held

1.43M

View Full List

About ILLUMINA, INC.

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $21.3B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

More about ILMN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Moors & Cabot, Inc. with notifications on news.

Account